Kairos Pharma Ltd.

1.73
-0.04 (-2.26%)
At close: Jan 17, 2025, 3:59 PM
1.73
0.00%
After-hours Jan 17, 2025, 06:30 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20
PE Ratio -14.9 -25.35 -15.57 -27.74
PS Ratio n/a n/a n/a n/a
PB Ratio -43.12 -22.57 -28.61 -85.06
P/FCF Ratio 333.25 -75.39 -81.04 -756.74
P/OCF Ratio 333.25 -75.39 -81.04 -756.74
OCF/S Ratio n/a n/a n/a n/a
Debt / Equity Ratio n/a -0.49 -0.33 -0.15
Quick Ratio 0.06 0.27 0.04 0.04
Current Ratio 0.06 0.27 0.04 0.04
Asset Turnover n/a n/a n/a n/a
Interest Coverage -17.49 -1.19 -9.62 -193.3
Return on Equity (ROE) 2.89 0.89 1.84 3.07
Return on Assets (ROA) -1.88 -1.01 -2.77 -73.48
Return on Capital (ROIC) 2.74 0.96 1.66 3.05
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a